MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Autonomic dysfunction"

  • 2024 International Congress

    Autonomic dysfunction and its impact on quality of life in Mexican people living with PD

    MF. Medina Pérez, D. Lopez Galindo, AJ. Hernandez Medrano, DP. Romero Terán, SF. Arechavala Lopez, G. Rivera Monroy, KI. Sanchez Ramirez, A. Abundes Corona, A. Cervantes Arriaga, M. Rodríguez Violante (Mexico, Mexico)

    Objective: To highlight the impact and correlation of autonomic dysfunction in motor symptoms, quality of life and caregiver burden from PwP Background: Autonomic dysfunction (AD)…
  • 2024 International Congress

    Transcranial Magnetic Stimulation of Median Prefrontal Cortex Improves Orthostatic Hypotension in Parkinson’s Disease

    S. Antipenko, A. Frohlich, M. Sklerov (Chapel Hill, USA)

    Objective: To evaluate transcranial magnetic stimulation (TMS) as a potential therapeutic tool for treatment of orthostatic hypotension (OH) in Parkinson’s disease (PD). Background: Autonomic dysfunction,…
  • 2024 International Congress

    Prognostic role of postganglionic cardiovascular dysfunction in Multiple System Atrophy

    R. Telese, A. Elia, R. Cilia, F. Colucci, V. Leta, A. Braccia, L. Romito, R. Eleopra, G. Devigili (Milan, Italy)

    Objective: To evaluate the role of reduced cardiac postganglionic sympathetic innervation as a prognostic factor in Multiple System Atrophy(MSA) Background: Cardiovascular autonomic dysfunction in MSA…
  • 2024 International Congress

    Long-term Blood Pressure Measures in Incident Parkinson’s Disease in the Framingham Heart Study.

    S. O'Shea, Y. Liu, Y. Li, A. Gurnani, J. Dookhy, S. Frank, R. Au, J. Mez, T. Ang, L. Shih (New York, USA)

    Objective: To assess the relationships of long-term blood pressure (BP) measures and incident Parkinson’s disease (PD) in the Framingham Heart Study (FHS) cohort. Background: Long-term…
  • 2024 International Congress

    Prevalence of autonomic symptoms in Multiple System Atrophy on the background of probable RBD

    H. Karkourian, L. Atabekyan, N. Nadryan, E. Balian, A. Grigoryan, S. Khachatryan, Z. Tavadyan (Yerevan, Armenia)

    Objective: To discover whether having probable rapid eye movement sleep behavior disorder (RBD) affects prevalence of particular autonomic symptoms, namely falls, constipation and urinary incontinence…
  • 2024 International Congress

    Cross-sectional study: what is the sleep quality, daytime sleepiness and quality of life like of people with parkinson’s disease at different stages of the disease?

    G. Leveck, L. Paladini, T. Christinelli, V. Israel (CURITIBA, Brazil)

    Objective: To verify sleep quality, daytime sleepiness and quality of life in the different stages of Parkinson's disease (PD). Background: The cholinergic, noradrenergic and serotonergic…
  • 2024 International Congress

    Impact of Temperature Variation on Emergency Department Visits for Parkinson’s Disease Patients Amongst Two Sites

    S. Vallamkonda, D. Petrosyan, B. Westbrook, N. Kakos, C. Hinds, R. Adlis, A. Menta, J. Lowry, D. Brooks, O. Hofheinz, P. Bhaya, J. Kong, M. Muppirala, A. Benchouia, A. Fajayan, A. Hohler, E. Vaou (Boston, USA)

    Objective: We aim to examine the impact of ambient temperature fluctuations on Parkinson’s disease (PD) patients across two distinct climates. Background: PD is a neurodegenerative…
  • 2024 International Congress

    Long-term Safety of Ampreloxetine in Patients with Symptomatic Neurogenic Orthostatic Hypotension

    R. Freeman, I. Biaggioni, R. Vickery, L. Norcliffe-Kaufmann, T. Guerin, M. Bryarly, V. Iodice, M. Rudzniska-Bar, M. Boczarska-Jedynak, C. Oehlwein, C. Shibao, H. Kaufmann (Boston, USA)

    Objective: To assess the long-term safety and tolerability of ampreloxetine in patients with synucleinopathies (MSA, PD, and PAF) and symptomatic neurogenic orthostatic hypotension (nOH) from…
  • 2023 International Congress

    Chronotropic incompetence – a possible marker of severe Parkinson’s disease phenotype?

    M. Andréasson, P. Svenningsson (Stockholm, Sweden)

    Objective: Perform a retrospective analysis of patients with Parkinson’s disease (PD) who previously have undergone a cardiac stress test, with the aim of comparing clinical…
  • 2023 International Congress

    Association between supine hypertension and plasma free triiodothyronine in drug-naïve Parkinson’s disease

    T. Umehara, T. Kokubu, J. Takahashi, T. Shiraishi, T. Sato, A. Onda, I. Iguchi (Tokyo, Japan)

    Objective: We aimed to clarify the association between thyroid hormone levels and supine hypertension (SH) in patients with early Parkinson’s disease (PD). Background: Increasing evidence…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 22
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley